CSIMarket Company Name, Ticker, Competitors, else..


Myriad Genetics Inc   (NASDAQ: MYGN)
Other Ticker:  
 

Myriad Genetics Inc

MYGN's Fundamental analysis



Looking into Myriad Genetics Inc growth rates, revenue grew by 11.15 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1005

In Vitro & In Vivo Diagnostic Substances industry recorded growth of revenues by 5.7 %

Myriad Genetics Inc net loss decreased from $-61 millions, to $-22 millions in III. Quarter 2024,

• More on MYGN's Growth


Myriad Genetics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 56.23 in trailing twelve-month period. In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.69.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 7.88.


• More on MYGN's Valuation
 
 Total Debt (Millions $) 39
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 305,037
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.92
 Tangible Book Value (Per Share $) 1.46

Myriad Genetics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 56.23 in trailing twelve-month period. In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.69.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 7.88.

Myriad Genetics Inc Price to Book Ratio is at 1.91 lower than Industry Avg. of 542.02. and higher than S&P 500 Avg. of 0.01

• More on MYGN's Valuation

•  Market Capitalization (Millions $) 1,394
•  Shares Outstanding (Millions) 91
•  Employees 2,700
•  Revenues (TTM) (Millions $) 824
•  Net Income (TTM) (Millions $) -116
•  Cash Flow (TTM) (Millions $) 25
•  Capital Exp. (TTM) (Millions $) -37
•  Total Debt (Millions $) 39
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 305,037
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 6.92
•  Tangible Book Value (Per Share $) 1.46

•  Market Capitalization (Millions $) 1,394
•  Shares Outstanding (Millions) 91
•  Employees 2,700
•  Revenues (TTM) (Millions $) 824
•  Net Income (TTM) (Millions $) -116
•  Cash Flow (TTM) (Millions $) 25
•  Capital Exp. (TTM) (Millions $) -37





  Ratio
•   Capital Ratio (MRQ) 1.9
•  Total Debt to Equity (MRQ) 0.05
•  Tangible Leverage Ratio (MRQ) 2.63
•  Asset Turnover Ratio (TTM) 0.79
•  Inventory Turnover Ratio (TTM) 10.28





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com